Controlling T cells via epigenetics
INSERM team proposes new autoimmune, immunodeficiency T cell targets in epigenetic pathway
An international academic team has discovered an epigenetic pathway that regulates CD4+ T cell differentiation and activity, and could yield new therapeutic targets for autoimmunity.
As drug developers seek the next generation of targeted therapies for autoimmune disease,
